A joint work by EPFL, ETH Zürich and the CHUV has identified a pathological process that takes place in both mice and humans towards one of the most common diseases that people face in the industrialized world: type 2 diabetes.
This work was conducted in Johan Auwerx's (EPFL) and Ruedi Aebersold's (ETH Zürich) laboratories, and succeeded thanks to the combination of each team's strengths. The relevance of their discovery, published today in Cell Metabolism, results from their joint effort.